Abstract
Specific pediatric populations have exhibited disparate responses to triiodothyronine (T3) repletion during and after cardiopulmonary bypass (CPB). Objective: To determine if T3 supplementation improves outcomes in children undergoing CPB. We searched randomized controlled trials (RCT) evaluating T3 supplementation in children aged 0–3 years undergoing CPB between 1/1/2000 and 1/31/2022. We calculated Hazard ratios (HR) for time to extubation (TTE), ICU length of stay (LOS), and hospital LOS. 5 RCTs met inclusion criteria with available patient-level data. Two were performed in United States (US) and 3 in Indonesia with 767 total subjects (range 29- 220). Median (IQR) age 4.1 (1.6, 8.0) months; female 43%; RACHS-1 scores: 1–1%; 2–55%; 3–27%; 4–13%; 5–0.1%; 6–3.9%; 54% of subjects in US vs 46% in Indonesia. Baseline TSH and T3 were lower in Indonesia (p < 0.001). No significant difference occurred in TTE between treatment groups overall [HR 1.09 (CI, 0.94–1.26)]. TTE numerically favored T3-treated patients aged 1–5 months [HR 1.24 (CI, 0.97–1.60)]. TTE HR for the Indonesian T3 group was 1.31 (CI, 1.04–1.65) vs. 0.95 (CI, 0.78–1.15) in US. The ICU LOS HR for the Indonesian T3 group was 1.19 vs. 0.89 in US (p = 0.046). There was a significant T3 effect on hospital LOS [HR 1.30 (CI, 1.01–1.67)] in Indonesia but not in US [HR 0.99 (CI, 0.78–1.23)]. T3 supplementation in children undergoing CPB is simple, inexpensive, and safe, showing benefit in resource-limited settings. Differences in effects between settings likely relate to depression in baseline thyroid function often associated with malnutrition.
Similar content being viewed by others
References
Bettendorf M, Schmidt KG, Tiefenbacher U et al (1997) Transient Secondary Hypothyroidism in Children after Cardiac Surgery. Pediatr Res 41:375–379. https://doi.org/10.1203/00006450-199703000-000122
Klemperer JD, Klein I, Gomez M et al (1995) Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery. New Engl J Medicine 333:1522–1527. https://doi.org/10.1056/nejm1995120733323023
Klemperer JD, Klein IL, Ojama K et al (1996) Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 61:1323–1329. https://doi.org/10.1016/0003-4975(96)00102-64
Mullis-Jansson SL, Argenziano M, Corwin S et al (1999) A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117:1128–1134. https://doi.org/10.1016/s0022-5223(99)70249-75
Files MD, Kajimoto M, Priddy CMO et al (2014) Triiodothyronine Facilitates Weaning From Extracorporeal Membrane Oxygenation by Improved Mitochondrial Substrate Utilization. J Am Heart Assoc 3:e000680. https://doi.org/10.1161/jaha.113.0006806
Olson AK, Bouchard B, Ning X-H et al (2012) Triiodothyronine increases myocardial function and pyruvate entry into the citric acid cycle after reperfusion in a model of infant cardiopulmonary bypass. Am J Physiol-heart C 302:H1086–H1093. https://doi.org/10.1152/ajpheart.00959.20117
Bettendorf M, Schmidt KG, Grulich-Henn J et al (2000) Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 356:529–534. https://doi.org/10.1016/s0140-6736(00)02576-9
Chowdhury D, Ojamaa K, Parnell VA et al (2001) A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 122:1023–1025. https://doi.org/10.1067/mtc.2001.1161929
Mackie AS, Booth KL, Newburger JW et al (2005) A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 130:810–816. https://doi.org/10.1016/j.jtcvs.2005.04.02510
Marwali EM, Boom CE, Budiwardhana N et al (2017) Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass. Ann Thorac Surg 104:688–695. https://doi.org/10.1016/j.athoracsur.2017.01.00111
Portman MA, Fearneyhough C, Ning X-H et al (2000) Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 120:604–608. https://doi.org/10.1067/mtc.2000.10890012
Talwar S, Bhoje A, Khadagawat R et al (2018) Oral thyroxin supplementation in infants undergoing cardiac surgery: A double-blind placebo-controlled randomized clinical trial. J Thorac Cardiovasc Surg 156:1209-1217.e3. https://doi.org/10.1016/j.jtcvs.2018.05.04413
Kumar A, Tiwari N, Ramamurthy HR et al (2021) A prospective randomized clinical study of perioperative oral thyroid hormone treatment for children undergoing surgery for congenital heart diseases. Ann Pediatric Cardiol 14:170–177. https://doi.org/10.4103/apc.apc_193_2014
Portman MA, Slee A, Olson AK et al (2010) Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC). Circulation 122:S224–S233. https://doi.org/10.1161/circulationaha.109.92639415
Portman MA, Slee AE, Roth SJ et al (2022) Triiodothyronine Supplementation in Infants Undergoing Cardiopulmonary Bypass: A Randomized Controlled Trial. Seminars Thorac Cardiovasc Surg. https://doi.org/10.1053/j.semtcvs.2022.01.00516
Marwali EM, Boom CE, Sakidjan I et al (2013) Oral Triiodothyronine Normalizes Triiodothyronine Levels After Surgery for Pediatric Congenital Heart Disease&ast. Pediatr Crit Care Med 14:701–708. https://doi.org/10.1097/pcc.0b013e3182917f8717
Marwali EM, Lopolisa A, Sani AA et al (2022) Indonesian Study: Triiodothyronine for Infants Less than 5 Months Undergoing Cardiopulmonary Bypass. Pediatr Cardiol 43:726–734. https://doi.org/10.1007/s00246-021-02779-818
Tharmapoopathy M, Thavarajah A, Kenny RPW et al (2022) Efficacy and Safety of Triiodothyronine Treatment in Cardiac Surgery or Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Thyroid. https://doi.org/10.1089/thy.2021.060919
Flores S, Loomba RS, Checchia PA et al (2020) Thyroid Hormone (Triiodothyronine) Therapy in Children After Congenital Heart Surgery: A Meta-Analysis. Seminars Thorac Cardiovasc Surg 32:87–95. https://doi.org/10.1053/j.semtcvs.2019.05.02020
Jenkins KJ, Gauvreau K, Newburger JW et al (2002) Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg 123:110–118. https://doi.org/10.1067/mtc.2002.11906421
Cantinotti M, Lorenzoni V, Storti S et al (2013) Thyroid and Brain Natriuretic Peptide Response in Children Undergoing Cardiac Surgery for Congenital Heart Disease: – Age-Related Variations and Prognostic Value –. Circ J 77:188–197. https://doi.org/10.1253/circj.cj-12-083422
Kaptein EM, Beale E, Chan LS (2009) Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metabolism 94:3663–3675. https://doi.org/10.1210/jc.2009-0899
Peeters RP (2007) Non thyroidal illness: to treat or not to treat? Ann D’endocrinologie 68:224–228. https://doi.org/10.1016/j.ando.2007.06.01124
Groot LJD (2006) Non-Thyroidal Illness Syndrome is a Manifestation of Hypothalamic-Pituitary Dysfunction, and in View of Current Evidence, Should be Treated with Appropriate Replacement Therapies. Crit Care Clin 22:57–86. https://doi.org/10.1016/j.ccc.2005.10.00125
Jonklaas J, Bianco AC, Bauer AJ et al (2014) Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 24:1670–1751. https://doi.org/10.1089/thy.2014.002826
Radman M, Portman M (2016) Thyroid Hormone in the Pediatric Intensive Care Unit. J Pediatr Intensiv Care 05:154–161. https://doi.org/10.1055/s-0036-158328027
Huang SA, Bianco AC (2008) Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pr Endocrinol Metab 4:148–155. https://doi.org/10.1038/ncpendmet072728
Heinle JS, Diaz LK, Fox LS, Tex F, the CCMC Fort Worth, (1997) Early extubation after cardiac operations in neonates and young infants. J Thorac Cardiovasc Surg 114:413–418. https://doi.org/10.1016/s0022-5223(97)70187-929
Morales DLS, Carberry KE, Heinle JS et al (2008) Extubation in the Operating Room After Fontan’s Procedure: Effect on Practice and Outcomes. Ann Thorac Surg 86:576–582. https://doi.org/10.1016/j.athoracsur.2008.02.01030
Chang R-KR, Chen AY, Klitzner TS (2000) Factors Associated With Age at Operation for Children With Congenital Heart Disease. Pediatrics 105:1073–1081. https://doi.org/10.1542/peds.105.5.107331
Marwali EM, Kekalih A, Yuliarto S et al (2022) Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity. Bmj Paediatr Open 6:e001657. https://doi.org/10.1136/bmjpo-2022-00165732
Marwali EM, Kekalih A, Haas NA (2012) The effect of malnutrition on T3 levels in pediatric patients undergoing congenital heart surgery. Critics Care & Shock 15:103–110
Ross FJ, Radman M, Jacobs ML et al (2020) Associations between anthropometric indices and outcomes of congenital heart operations in infants and young children: An analysis of data from the Society of Thoracic Surgeons Database. Am Hear J 224:85–97. https://doi.org/10.1016/j.ahj.2020.03.01234
Ross F, Latham G, Joffe D et al (2017) Preoperative malnutrition is associated with increased mortality and adverse outcomes after paediatric cardiac surgery. Cardiol Young 27:1716–1725. https://doi.org/10.1017/s104795111700106835
Radman M, Mack R, Barnoya J et al (2014) The effect of preoperative nutritional status on postoperative outcomes in children undergoing surgery for congenital heart defects in San Francisco (UCSF) and Guatemala City (UNICAR). J Thorac Cardiovasc Surg 147:442–450. https://doi.org/10.1016/j.jtcvs.2013.03.02336
Zimmermann-Belsing T, Brabant G, Holst J, Feldt-Rasmussen U (2003) Circulating leptin and thyroid dysfunction. Eur J Endocrinol 149:257–271. https://doi.org/10.1530/eje.0.149025737
Warner MH, Beckett GJ (2010) Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 205:1–13. https://doi.org/10.1677/joe-09-041238
Mebis L, van den Berghe G (2009) The hypothalamus-pituitary-thyroid axis in critical illness. Neth J Med 67:332–340
Funding
No funds, grants, or other support was received.
Author information
Authors and Affiliations
Contributions
MR, AS, EM and MP: conceptualization; MR, AS and MP: methodology; MR, AS and MP: formal analysis and investigation; MR, AS and MP: writing - original draft preparation; MR, EM, AS and MP - review and editing; MR and MP - supervision.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no financial or non-financial competing interests.
Ethical Approval
This study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments of comparable ethical standards.
Informed Consent
Written and informed consent were taken from the parents before participation in each included study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Radman, M.R., Slee, A.E., Marwali, E.M. et al. Triiodothyronine Supplementation for Children Undergoing Cardiopulmonary Bypass: A Meta-Analysis. Pediatr Cardiol (2024). https://doi.org/10.1007/s00246-024-03465-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00246-024-03465-1